60 Degrees Pharmaceuticals (SXTP) Institutional Ownership $0.45 -0.02 (-4.74%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.45 +0.00 (+0.89%) As of 02/21/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for 60 Degrees Pharmaceuticals (NASDAQ:SXTP)CurrentInstitutional OwnershipPercentage7.96%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$48.77K Get SXTP Insider Trade Alerts Want to know when executives and insiders are buying or selling 60 Degrees Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address 60 Degrees Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/19/2024 Central Bank & Trust Co.167,000$42K0.0%-37.7%1.368% 4/11/2024 Central Bank & Trust Co.268,000$70K0.0%-24.9%4.613% 1/9/2024 Central Bank & Trust Co.357,000$361K0.1%-23.7%6.155% (Data available from 1/1/2016 forward) SXTP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SXTP shares? During the previous two years, the following institutional investors and hedge funds held shares of 60 Degrees Pharmaceuticals shares: Central Bank & Trust Co. ($42K).Learn more on SXTP's institutional investors. What percentage of 60 Degrees Pharmaceuticals stock is owned by institutional investors? 7.96% of 60 Degrees Pharmaceuticals stock is owned by institutional investors. Learn more on SXTP's institutional investor holdings. Which 60 Degrees Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold 60 Degrees Pharmaceuticals stock in the last 24 months: Central Bank & Trust Co. ($301K). How much institutional selling is happening at 60 Degrees Pharmaceuticals? Institutional investors have sold a total of 301,000 shares in the last 24 months. This volume of shares sold represents approximately $161.99K in transactions. Related Companies CLLS Institutional Ownership SCLX Institutional Ownership TARA Institutional Ownership IGMS Institutional Ownership ALGS Institutional Ownership TLSA Institutional Ownership VTGN Institutional Ownership CLSD Institutional Ownership THTX Institutional Ownership ASRT Institutional Ownership This page (NASDAQ:SXTP) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 60 Degrees Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 60 Degrees Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
